Which therapy is contraindicated in the management of sickle cell anemia?

Which therapy is contraindicated in the management of sickle cell anemia?

• A. Hydroxyurea
• B. Oxygen therapy
• C. Adequate hydration
• D. Pain management

Answer: (A)

In managing sickle cell disease, the goal is to prevent further sickling and complications by supporting hydration, relieving pain, and ensuring adequate oxygenation when needed. Hydration helps reduce blood viscosity and supports perfusion during crises. Pain management is essential to break the cycle of vaso-occlusion and stress. Oxygen therapy is used during episodes of hypoxemia or acute chest symptoms to improve tissue oxygen delivery. Hydroxyurea, a disease-modifying medication, increases fetal hemoglobin (HbF) production, which reduces the frequency of painful crises, acute chest syndrome, and transfusion needs. It is not routinely contraindicated; in fact, it is recommended for many adults with frequent crises or severe disease, provided there are no contraindications. The main exceptions are pregnancy, breastfeeding, or significant bone marrow suppression (and related organ dysfunction), where its use is avoided. Therefore, there is no absolute contraindication for these standard management therapies in general practice; hydroxyurea is typically beneficial and used chronically rather than avoided.

In managing sickle cell disease, the goal is to prevent further sickling and complications by supporting hydration, relieving pain, and ensuring adequate oxygenation when needed. Hydration helps reduce blood viscosity and supports perfusion during crises. Pain management is essential to break the cycle of vaso-occlusion and stress. Oxygen therapy is used during episodes of hypoxemia or acute chest symptoms to improve tissue oxygen delivery.

Hydroxyurea, a disease-modifying medication, increases fetal hemoglobin (HbF) production, which reduces the frequency of painful crises, acute chest syndrome, and transfusion needs. It is not routinely contraindicated; in fact, it is recommended for many adults with frequent crises or severe disease, provided there are no contraindications. The main exceptions are pregnancy, breastfeeding, or significant bone marrow suppression (and related organ dysfunction), where its use is avoided.

Therefore, there is no absolute contraindication for these standard management therapies in general practice; hydroxyurea is typically beneficial and used chronically rather than avoided.